Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S. Nagar, Punjab-160 062, India.
Brain Res. 2010 Apr 23;1327:118-24. doi: 10.1016/j.brainres.2010.02.063. Epub 2010 Feb 26.
To gain insight into the early and late changes in protein expression following focal transient cerebral ischemia in rat, proteomic approach was undertaken. Proteomic profiling using two-dimensional gel electrophoresis indicated upregulation of albumin protein after 2h of ischemia and 22h of reperfusion among the other altered proteins. Further, the albumin overexpression was verified by quantitative real time PCR at mRNA level, validated by western blotting and immunohistochemistry. Although, exogenous human albumin therapy is already under clinical trials for cerebral ischemia, its endogenous expression in ischemic rat brain at mRNA and protein levels has not been investigated as yet. Here we report for the first time de novo synthesis of albumin in the ischemic rat brain. This study paves the way for further investigation of signaling mechanisms leading to albumin overexpression, so that it can be exploited as a therapeutic intervention.
为了深入了解大鼠局灶性短暂性脑缺血后早期和晚期蛋白质表达的变化,采用了蛋白质组学方法。二维凝胶电泳的蛋白质组学分析表明,在缺血 2 小时和再灌注 22 小时后,白蛋白蛋白表达上调。此外,通过实时定量 PCR 在 mRNA 水平上进一步验证了白蛋白的过表达,并通过 Western blot 和免疫组织化学进行了验证。尽管外源性人白蛋白治疗已经在脑缺血的临床试验中进行,但迄今为止尚未研究其在缺血性大鼠脑中的 mRNA 和蛋白质水平的内源性表达。在这里,我们首次报道了在缺血性大鼠脑中从头合成白蛋白。这项研究为进一步研究导致白蛋白过表达的信号机制铺平了道路,以便可以将其作为一种治疗干预措施加以利用。